Cardinal Health's CEO salary and other executives compensation in 2025 was as follows:
CEO/ Executive salary tells one part of the story. Explore Employee Count Trend, Revenue per Employee, and Profit per Employee to understand workforce scale, and employee productivity.
Jason M. Hollar Chief Executive Officer, at Cardinal Health, received $1.49 M in base salary, $13.43 M in stock award, and $500.68 K in other compensation, making $18.98 M in total compensation in 2025.
The total compensation was -26.02% down from the previous year, 2024.
Aaron E. Alt Chief Financial Officer, at Cardinal Health, received $871.16 K in base salary, $3.98 M in stock award, and $57.80 K in other compensation, making $6.21 M in total compensation in 2025.
The total compensation was -9.25% down from the previous year, 2024.
Deborah L. Weitzman Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment, at Cardinal Health, received $741.93 K in base salary, $3.77 M in stock award, and $30.20 K in other compensation, making $5.51 M in total compensation in 2025.
The total compensation was +8.23% up from the previous year, 2024.
Jessica L. Mayer Chief Legal and Compliance Officer, at Cardinal Health, received $716.93 K in base salary, $3.20 M in stock award, and $30.45 K in other compensation, making $4.93 M in total compensation in 2025.
The total compensation was +5.74% up from the previous year, 2024.
Stephen M. Mason Chief Executive Officer, Global Medical Products and Distribution Segment, at Cardinal Health, received $741.93 K in base salary, $3.36 M in stock award, and $51.65 K in other compensation, making $4.75 M in total compensation in 2025.
The total compensation was -35.33% down from the previous year, 2024.
Sign in to download table
| Executive | 2025 | 2024 | 2023 |
|---|---|---|---|
|
Jason M. Hollar Chief Executive Officer
|
$18.98 M | •••••••• | •••••••• |
| Base Salary | $1.49 M | •••••••• | •••••••• |
| Incentive Plan Compensation | $3.55 M | •••••••• | •••••••• |
| All Other Compensation | $500.68 K | •••••••• | •••••••• |
| Stock Award | $13.43 M | •••••••• | •••••••• |
|
Aaron E. Alt Chief Financial Officer
|
$6.21 M | •••••••• | •••••••• |
| Base Salary | $871.16 K | •••••••• | •••••••• |
| Incentive Plan Compensation | $1.30 M | •••••••• | •••••••• |
| All Other Compensation | $57.80 K | •••••••• | •••••••• |
| Stock Award | $3.98 M | •••••••• | •••••••• |
|
Deborah L. Weitzman Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment
|
$5.51 M | •••••••• | •••••••• |
| Base Salary | $741.93 K | •••••••• | •••••••• |
| Incentive Plan Compensation | $964.51 K | •••••••• | •••••••• |
| All Other Compensation | $30.20 K | •••••••• | •••••••• |
| Stock Award | $3.77 M | •••••••• | •••••••• |
|
Jessica L. Mayer Chief Legal and Compliance Officer
|
$4.93 M | •••••••• | •••••••• |
| Base Salary | $716.93 K | •••••••• | •••••••• |
| Incentive Plan Compensation | $975.03 K | •••••••• | •••••••• |
| All Other Compensation | $30.45 K | •••••••• | •••••••• |
| Stock Award | $3.20 M | •••••••• | •••••••• |
|
Stephen M. Mason Chief Executive Officer, Global Medical Products and Distribution Segment
|
$4.75 M | •••••••• | •••••••• |
| Base Salary | $741.93 K | •••••••• | •••••••• |
| Incentive Plan Compensation | $593.55 K | •••••••• | •••••••• |
| All Other Compensation | $51.65 K | •••••••• | •••••••• |
| Stock Award | $3.36 M | •••••••• | •••••••• |
|
Jason M. Hollar Chief Executive Officer and Former Chief Financial Officer
|
- | •••••••• | •••••••• |
| Base Salary | - | •••••••• | •••••••• |
| Incentive Plan Compensation | - | •••••••• | •••••••• |
| All Other Compensation | - | •••••••• | •••••••• |
| Stock Award | - | •••••••• | •••••••• |
|
Victor L. Crawford Former Chief Executive Officer, Pharmaceutical Segment
|
- | •••••••• | •••••••• |
| Base Salary | - | •••••••• | •••••••• |
| Incentive Plan Compensation | - | •••••••• | •••••••• |
| All Other Compensation | - | •••••••• | •••••••• |
| Stock Award | - | •••••••• | •••••••• |
|
Stephen M. Mason Chief Executive Officer, Medical Segment
|
- | •••••••• | •••••••• |
| Base Salary | - | •••••••• | •••••••• |
| Incentive Plan Compensation | - | •••••••• | •••••••• |
| All Other Compensation | - | •••••••• | •••••••• |
| Stock Award | - | •••••••• | •••••••• |
|
Deborah L. Weitzman Chief Executive Officer, Pharmaceutical Segment
|
- | •••••••• | •••••••• |
| Base Salary | - | •••••••• | •••••••• |
| Incentive Plan Compensation | - | •••••••• | •••••••• |
| All Other Compensation | - | •••••••• | •••••••• |
| Stock Award | - | •••••••• | •••••••• |
|
Michael C. Kaufmann Former Chief Executive Officer
|
- | •••••••• | •••••••• |
| Base Salary | - | •••••••• | •••••••• |
| Incentive Plan Compensation | - | •••••••• | •••••••• |
| All Other Compensation | - | •••••••• | •••••••• |
| Stock Award | - | •••••••• | •••••••• |
|
Patricia M. English Former Interim Chief Financial Officer
|
- | •••••••• | •••••••• |
| Base Salary | - | •••••••• | •••••••• |
| Incentive Plan Compensation | - | •••••••• | •••••••• |
| All Other Compensation | - | •••••••• | •••••••• |
| Stock Award | - | •••••••• | •••••••• |